Intra-Cellular Therapies Inc (ITCI) - Financial and Strategic SWOT Analysis Review

  • ID: 4281528
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Intra Cellular Therapies Inc
1 of 4

Intra-Cellular Therapies Inc (ITI) is a biopharmaceutical company that discovers and develops novel drugs for the treatment of neuropsychiatric and neurologic disorders. The company’s lead product candidate include ITI-007-lumateperone, which is intended for the treatment of schizophrenia, behavioral disturbances in dementia, sleep and behavioral disturbances associated with autism spectrum disorder, other mood disorders, sleep disturbances associated with neurologic and psychiatric disorders, and others. Its lead candidate lumateperone is in phase III clinical development for the treatment of schizophrenia, bipolar depression, and agitation associated with dementia and alzheimer's disease. The company utilizes phosphodiesterase platform and other proprietary chemistry platforms to develop drugs for the treatment of central nervous system and other disorders. ITI is headquartered in New York, the US.

Intra-Cellular Therapies Inc Key Recent Developments

Mar 01, 2018: Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
Nov 13, 2017: Intra-Cellular Therapies Expands Its Executive Team with the Appointment of Dr. Andrew Satlin as Executive Vice President and Chief Medical Officer
Nov 08, 2017: Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Aug 09, 2017: Intra-Cellular Therapies Reports Second Quarter 2017 Financial Results and Provides Corporate Update
May 10, 2017: Intra-Cellular Therapies Reports First Quarter 2017 Financial Results and Provides Corporate Update

This comprehensive SWOT profile of Intra-Cellular Therapies Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intra-Cellular Therapies Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Intra-Cellular Therapies Inc - Key Information
  • Intra-Cellular Therapies Inc - Overview
  • Intra-Cellular Therapies Inc - Key Employees
  • Intra-Cellular Therapies Inc - Key Employee Biographies
  • Intra-Cellular Therapies Inc - Key Operational Heads
  • Intra-Cellular Therapies Inc - Major Products and Services
  • Intra-Cellular Therapies Inc - History
  • Intra-Cellular Therapies Inc - Company Statement
  • Intra-Cellular Therapies Inc - Locations And Subsidiaries
  • Intra-Cellular Therapies Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Intra-Cellular Therapies Inc - Business Description
  • Intra-Cellular Therapies Inc - Corporate Strategy
  • Intra-Cellular Therapies Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Intra-Cellular Therapies Inc - Strengths
  • Intra-Cellular Therapies Inc - Weaknesses
  • Intra-Cellular Therapies Inc - Opportunities
  • Intra-Cellular Therapies Inc - Threats
  • Intra-Cellular Therapies Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Intra-Cellular Therapies Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Intra-Cellular Therapies Inc, Key Information
  • Intra-Cellular Therapies Inc, Key Ratios
  • Intra-Cellular Therapies Inc, Share Data
  • Intra-Cellular Therapies Inc, Major Products and Services
  • Intra-Cellular Therapies Inc, History
  • Intra-Cellular Therapies Inc, Key Employees
  • Intra-Cellular Therapies Inc, Key Employee Biographies
  • Intra-Cellular Therapies Inc, Key Operational Heads
  • Intra-Cellular Therapies Inc, Other Locations
  • Intra-Cellular Therapies Inc, Subsidiaries
  • Intra-Cellular Therapies Inc, Key Manufacturing facilities
  • Intra-Cellular Therapies Inc, Key Competitors
  • Intra-Cellular Therapies Inc, SWOT Analysis
  • Intra-Cellular Therapies Inc, Ratios based on current share price
  • Intra-Cellular Therapies Inc, Annual Ratios
  • Intra-Cellular Therapies Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Intra-Cellular Therapies Inc, Performance Chart
  • Intra-Cellular Therapies Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown